Trials / Completed
CompletedNCT02502123
Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®
Multi-Centre, Prospective, Observational Study of Patient Reported Outcomes in Patients Diagnosed With Chronic Migraine and Treated With OnabotulinumtoxinA for Injection (BOTOX®) (PREDICT)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 215 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | No intervention was administered in this study. |
Timeline
- Start date
- 2015-07-02
- Primary completion
- 2019-01-29
- Completion
- 2019-01-29
- First posted
- 2015-07-20
- Last updated
- 2019-04-05
Locations
15 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02502123. Inclusion in this directory is not an endorsement.